Looking to the Future: Innovative Approaches to #HIV #Vaccine Development and Immunotherapies

We had the pleasure of welcoming Dr Charles Nicolette, the Chief Scientific Officer and R&D Vice President at Argos Therapeutics at the most recent World Vaccine Congress Washington in April to hear about his work on personalised HIV treatment to patient's own virus strain. Dr Nicolette shared his findings on personalizing RNA-loaded dendritic cell immunotherapies for cancer, HIV and other …